YGen Healthcare is planning to scale up its beta thalassemia DNA-based prenatal detection services. This initiative has garnered appreciation from NITI Aayog, Government of India, for its potential to significantly improve early diagnosis and management of beta thalassemia. By expanding these services, YGen Healthcare aims to provide advanced prenatal screening to a broader population, enhancing healthcare outcomes and contributing to national health goals.

YGen Healthcare is set to collaborate with Rooloc Co. Ltd, Korea, to venture into the manufacturing of artificial knees. This partnership aims to enhance the quality and availability of advanced orthopedic solutions.